Zen Chu is Managing Director of Accelerated Medical Ventures, specializing in building early-stage medical technology and healthcare service companies, usually serving as co-founder and first investor. AMV's portfolio spans Boston, Silicon Valley and China.
Alongside four world-renowned MIT biomaterials professors, Zen co-founded and served as CEO for 3D-Matrix Medical Inc., a venture-backed MIT regenerative medicine company whose products are treating patients and enabling new regenerative medicine research, with a successful IPO in 2011. He has managed and led new ventures for Harvard Medical School, Harvard's Wyss Institute for Bioengineering, NetVentures, and Hewlett-Packard.
Zen earned a Masters of Public & Private Management from Yale University and a BS in biomedical/electrical engineering from SMU.